Denali Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Bellevue Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $320k | 16k | 20.38 |
| 2024-09-30 | $457k | 16k | 29.13 |
| 2023-06-30 | $1.3M | 44k | 29.51 |
| 2023-03-31 | $714k | 31k | 23.04 |
| 2022-12-31 | $862k | 31k | 27.81 |
| 2022-09-30 | $951k | 31k | 30.68 |